Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection.
Journal article
Gu Q. et al, (2024), The Journal of infection
Target enrichment improves culture-independent detection of Neisseria gonorrhoeae and antimicrobial resistance determinants direct from clinical samples with Nanopore sequencing
Journal article
Street TL. et al, (2024), Microbial Genomics, 10
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.
Journal article
AMR-X Collaborators None., (2024), The Lancet. Microbe
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
Journal article
Sartorius B. et al, (2024), The Lancet Global Health, 12, e201 - e216
Genomic epidemiology of Candida auris introduction and outbreaks in the United Kingdom
Preprint
Kappel D. et al, (2024)
Target enrichment improves culture-independent detection ofNeisseria gonorrhoeaedirect from sample with Nanopore sequencing
Preprint
Street TL. et al, (2024)
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Journal article
Bešević J. et al, (2023), Journal of epidemiology and community health
The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding surveillance using existing laboratory and register data.
Journal article
Danielsen AS. et al, (2023), European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
The burden and dynamics of hospital-acquired SARS-CoV-2 in England.
Journal article
Cooper BS. et al, (2023), Nature
Evaluation of sequence hybridization for respiratory viruses using the Twist Bioscience Respiratory Virus Research panel and the OneCodex Respiratory Virus sequence analysis workflow.
Journal article
Kapel N. et al, (2023), Microbial genomics, 9
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis
Journal article
Aguilar GR. et al, (2023), The Lancet Regional Health - Americas, 25, 100561 - 100561
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
Journal article
Eyre DW. et al, (2023), The Lancet. Infectious diseases, 23, 922 - 932
Algorithmic fairness and bias mitigation for clinical machine learning with deep reinforcement learning
Journal article
Yang J. et al, (2023), Nature Machine Intelligence
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Preprint
Wei J. et al, (2023)
Integrating at-scale health data into doctoral training (Preprint)
Preprint
Nichols TE. et al, (2023)
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Journal article
Wei J. et al, (2023), Nature Communications, 14
Comparing genomic variant identification protocols for Candida auris.
Journal article
Li X. et al, (2023), Microb Genom, 9
An adversarial training framework for mitigating algorithmic biases in clinical machine learning
Journal article
Yang J. et al, (2023), npj Digital Medicine, 6
The quality of vital signs measurements and value preferences in electronic medical records varies by hospital, specialty, and patient demographics
Journal article
Jackson N. et al, (2023), Scientific Reports, 13
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Preprint
Pouwels KB. et al, (2023)
Self-Aware SGD: Reliable Incremental Adaptation Framework For Clinical AI Models
Preprint
Thakur A. et al, (2023)
Improving patient flow through hospitals with machine learning based discharge prediction
Preprint
Zhou J. et al, (2023)
Mode Connections For Clinical Incremental Learning: Lessons From The COVID-19 Pandemic
Preprint
Thakur A. et al, (2023)
Self-Aware SGD: Reliable Incremental Adaptation Framework For Clinical AI Models
Journal article
Thakur A. et al, (2023), IEEE Journal of Biomedical and Health Informatics, 1 - 11
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study.
Journal article
Ward V. et al, (2022), BMJ open, 12
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins
Journal article
Kuehn R. et al, (2022), Cochrane Database of Systematic Reviews, 2022
Benchmarking taxonomic classifiers with Illumina and Nanopore sequence data for clinical metagenomic diagnostic applications
Journal article
Govender KN. and Eyre DW., (2022), Microbial Genomics, 8
Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels
Journal article
Gu Q. et al, (2022), Journal of Infection, 85, 382 - 389
RapiD_AI: A framework for Rapidly Deployable AI for novel disease & pandemic preparedness
Preprint
Youssef A. et al, (2022)
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar
Preprint
Pritchard E. et al, (2022)
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Journal article
Wellens J. et al, (2022), Gut, 71, 1919 - 1922
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology.
Journal article
Perkmann T. et al, (2022), Journal of clinical pathology
Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records
Journal article
Yoon CH. et al, (2022), Journal of Antimicrobial Chemotherapy, 77, 2536 - 2545
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom
Journal article
Vihta KD. et al, (2022), Clinical Infectious Diseases, 75, e329 - e337
RapiD_AI: A framework for Rapidly Deployable AI for novel disease & pandemic preparedness
Preprint
Youssef A. et al, (2022)
Time-of-Day Variation in SARS-CoV-2 RNA Levels during the Second Wave of COVID-19
Journal article
Zhuang X. et al, (2022), Viruses, 14, 1728 - 1728
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Journal article
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers
Journal article
Phillips E. et al, (2022), Clinical and Experimental Immunology, 209, 90 - 98
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
Journal article
McNaughton AL. et al, (2022), JCI Insight, 7
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Journal article
Wei J. et al, (2022), Nature Communications, 13
Chest CT and Hospital Outcomes in Patients with Omicron Compared with Delta Variant SARS-CoV-2 Infection.
Journal article
Tsakok MT. et al, (2022), Radiology
CO-CONNECT: A hybrid architecture to facilitate rapid discovery and access to UK wide data in the response to the COVID-19 pandemic (Preprint)
Journal article
Jefferson E. et al, (2022), Journal of Medical Internet Research